| 1 |
GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019 [J]. Lancet Neurol, 2021, 20(10): 795-820.
|
| 2 |
Seners P, Baron JC. Revisiting 'progressive stroke': incidence, predictors, pathophysiology, and management of unexplained early neurological deterioration following acute ischemic stroke [J]. Neurol, 2018, 265(1): 216-225.
|
| 3 |
Siegler JE, Martin-Schild S. Early neurological deterioration (END) after stroke: the END depends on the definition [J]. Int J Stroke, 2011, 6(3): 211-212.
|
| 4 |
胡孟良, 李敏, 钟孟飞, 等. 穿支动脉粥样硬化病患者早期神经功能恶化的研究进展 [J]. 中国脑血管病杂志, 2025, 22(4): 264-269.
|
| 5 |
宋水江, 荆山. 进展性缺血性脑卒中研究进展 [J]. 心电与循环, 2022, 41(2): 117-123, 133.
|
| 6 |
Saver JL, Altman H. Relationship between neurologic deficit severity and final functional outcome shifts and strengthens during first hours after onset [J]. Stroke, 2012, 43(6): 1537-1541.
|
| 7 |
Philip B, John E, David B. Progressing stroke: towards an internationally agreed definition [J]. Cerebrovasc Dis, 2004, 17(2-3): 242-252.
|
| 8 |
Luvizutto GJ, Gabriel MG, Braga GP, et al. Aspects correlates with Scandinavian Stroke Scale for predicting early neurological impairment [J]. Arq Neuropsiquiatr, 2015, 73(5): 450-453.
|
| 9 |
Duan Z, Sun W, Liu W, et al. Acute diffusion-weighted imaging lesion patterns predict progressive small subcortical infarct in the perforator territory of the middle cerebral artery [J]. Int J Stroke, 2015, 10(2): 207-212.
|
| 10 |
Duan Z, Fu C, Chen B, et al. Lesion patterns of single small subcortical infarct and its association with early neurological deterioration [J]. Neurol Sci, 2015, 36(10): 1851-1857.
|
| 11 |
GBD 2021 Stroke Risk Factor Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 [J]. Lancet Neurol, 2024, 23(10): 973-1003.
|
| 12 |
Jeong HG, Kim BJ, Kim H, et al. Blood pressure drop and penumbral tissue loss in nonrecanalized emergent large vessel occlusion [J]. Stroke, 2019, 50(10): 2677-2684.
|
| 13 |
Dungan KM, Baithwaite SS, Periser JC. Stress hyperglycaemia [J]. Lancet, 2009, 373(9677): 1798-1807.
|
| 14 |
An Y, Xu BT, Wan SR, et al. The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction [J]. Cardiovasc Diabetol, 2023, 22(1): 237.
|
| 15 |
Mi D, Wang Y, Wang Y, et al. Insulin resistance is an independent risk factor for early neurological deterioration in non-diabetic patients with acute ischemic stroke [J]. Neurol Sci, 2020, 41(6): 1467-1473.
|
| 16 |
Scheidecker E, Pereira ZB, Potreck A, et al. Role of diabetes in collateral status assessed in CT perfusion-derived dynamic CTA in anterior circulation stroke [J]. Neuroradiology, 2022, 64(6): 1195-1199.
|
| 17 |
Kloska A, Malnowska M, Gabig CM, et al. Lipids and lipid mediators associated with the risk and pathology of ischemic stroke [J]. Int J Mol Sci, 2020, 21(10): 3618.
|
| 18 |
Amarenco P, Kim JS, Labreuche J, et al. A comparison of two LDL cholesterol targets after ischemic stroke [J]. N Engl J Med, 2020, 382(1): 9.
|
| 19 |
Ryu WS, Schellingerhout D, Jeong SW, et al. Association between serum lipid profiles and early neurological deterioration in acute ischemic stroke [J]. J Stroke Cerebrovasc Dis, 2016, 25(8): 2024-2030.
|
| 20 |
Clausen BH, Wirenfeldt M, Høgedal SS, et al. Characterization of the TNF and IL-1 systems in human brain and blood after ischemic stroke [J]. Acta Neuropathol Commun, 2020, 8(1): 81.
|
| 21 |
Zhu H, Hu S, Li Y, et al. Interleukins and ischemic stroke [J]. Front Immunol, 2022, 13: 828447.
|
| 22 |
Cekanaviciute E, Buckwalter MS. Astrocytes: integrative regulators of neuroinflammation in stroke and other neurological diseases [J]. Neurotherapeutics, 2016, 13(4): 685-701.
|
| 23 |
Maida CD, Norrito RL, Daidone M, et al. Neuroinflammatory mechanisms in ischemic stroke: focus on cardioembolic stroke, background, and therapeutic approaches [J]. Int J Mol Sci, 2020, 21(18): 6454.
|
| 24 |
Ohk T, Ahn J, Park Y, et al. Comparison of neuronal death and expression of TNF-α and MCT4 in the gerbil hippocampal CA1 region induced by ischemia/reperfusion under hyperthermia to those under normothermia [J]. Mol Med Rep, 2020, 22(2): 1044-1052.
|
| 25 |
Geurts M, Scheijmans F, van Seeters T, et al. Temporal profile of body temperature in acute ischemic stroke: relation to infarct size and outcome [J]. BMC Neurol, 2016, 16(1): 233.
|
| 26 |
Mezutki S, Matsuo R, Irie F, et al. Body temperature in the acute phase and clinical outcomes after acute ischemic stroke [J]. PLoS One, 2024, 19(1): e0296639.
|
| 27 |
Neves D, Salazar IL, Almeida RD, et al. Molecular mechanisms of ischemia and glutamate excitotoxicity [J]. Life Sci, 2023, 328: 121814.
|
| 28 |
Jeong YY, Yoo JH, Jeong SY, et al. LY-2183240 enhances reward-seeking behavior with inducing neuronal excitation and early apoptosis in mouse [J]. iScience, 2024, 27(11): 111069.
|
| 29 |
Iglesias RR, Da SA, Rodriguez YM, et al. Neurological instability in ischemic stroke: relation with outcome, latency time, and molecular markers [J]. Transl Stroke Res, 2022, 13(2): 228-237.
|
| 30 |
Kaplan AO, Acari A, Ciftci P, et al. Glutamate scavenging as a neuroreparative strategy in ischemic stroke [J]. Front Pharmacol, 2022, 13: 866738.
|
| 31 |
Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack [J]. N Engl J Med, 2013, 369(1): 11-19.
|
| 32 |
Lin J, Mo Y, Cai D, et al. CYP2C19 polymorphisms and clopidogrel efficacy in the secondary prevention of ischemic stroke: a retrospective observational study [J]. Ann Palliat Med, 2021, 10(12): 12171-12180.
|
| 33 |
Jafrin S, Naznin NE, Reza MS, et al. Risk of stroke in CYP2C19 LoF polymorphism carrier coronary artery disease patients undergoing clopidogrel therapy: an ethnicity-based updated Meta-analysis [J]. Eur J Intern Med, 2021, 90: 49-65.
|
| 34 |
Wang Y, Meng X, Wang A, et al. Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA [J]. N Engl J Med, 2021, 385(27): 2520-2530.
|
| 35 |
Ciccone A, Motto C, Abraha I, et al. Glycoprotein Ⅱb-Ⅲa inhibitors for acute ischaemic stroke [J]. Cochrane Database Syst Rev, 2014, (3): CD005208.
|
| 36 |
Du N, Wang LX, Liu YL, et al. Effect of tirofiban in treating patients with progressive ischemic stroke [J]. Eur Rev Med Pharmacol Sci, 2022, 26(6): 2098-2105.
|
| 37 |
Zhao W, Li S, Li C, et al. Effects of tirofiban on neurological deterioration in patients with acute ischemic stroke: a randomized clinical trial [J]. JAMA Neurol, 2024, 81(6): 594-602.
|
| 38 |
Wang J, Li S, Li C, et al. Safety and efficacy of tirofiban in preventing neurological deterioration in acute ischemic stroke (TREND): protocol for an investigator-initiated, multicenter, prospective, randomized, open-label, masked endpoint trial [J]. Brain Circ, 2024, 10(2): 168-173.
|
| 39 |
Liao X, Feng S, Wang Y, et al. Tirofiban combined with aspirin in the treatment of acute penetrating artery territory infarction (STRATEGY): protocol for a multicentre, randomised controlled trial [J]. Stroke Vasc Neurol, 2024, 9(1): 75-81.
|
| 40 |
Seners P, Hurford R, Tisserand M, et al. Is unexplained early neurological deterioration after intravenous thrombolysis associated with thrombus extension? [J]. Stroke, 2017, 48(2): 348-352.
|
| 41 |
Li H, Dai Y, Wu H, et al. Predictors of early neurologic deterioration in acute pontine infarction [J]. Stroke, 2020, 51(2): 637-640.
|
| 42 |
Barreto A, Alexandrov A, Lyden P, et al. The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study [J]. Stroke, 2012, 43(3): 770-775.
|
| 43 |
Zhang X, Zhong W, Xue R, et al. Argatroban in patients with acute ischemic stroke with early neurological deterioration: a randomized clinical trial [J]. JAMA Neurol, 2024, 81(2): 118-125.
|
| 44 |
Ye Y, Zhou W, Cheng W, et al. Short-term and long-term safety and efficacy of treatment of acute ischemic stroke with low-molecular-weight heparin: Meta-analysis of 19 randomized controlled trials [J]. World Neurosurg, 2020, 141: e26-e41.
|
| 45 |
Qiu T, Li C, Huang L, et al. Tirofiban combined with heparin's effect and safety in the treatment of mild to moderate acute ischemic stroke [J]. Neurol Res, 2021, 43(3): 220-224.
|
| 46 |
Robinson AA, Ikuta K, Soverow J. Anticoagulation for the acute management of ischemic stroke [J]. Yale J Biol Med, 2014, 87(2): 199-206.
|
| 47 |
Froio NL, Montgomery RM, David NE, et al. Anticoagulation in acute ischemic stroke: a systematic search [J]. Rev Assoc Med Bras (1992), 2017, 63(1): 50-56.
|
| 48 |
王明, 陈建明. 阿加曲班与低分子肝素钙治疗急性脑梗死的疗效研究 [J]. 临床神经病学杂志, 2014, 27(4): 320.
|
| 49 |
Yadav K, Sharma M, Ferdinand KC. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: present perspectives and future horizons [J]. Nutr Metab Cardiovasc Dis, 2016, 26(10): 853-862.
|
| 50 |
Moustafa B, Oparowski D, Testal S, et al. Efficacy and safety of PCSK9 inhibitors for stroke prevention: systematic review and Meta-analysis [J]. J Stroke Cerebrovasc Dis, 2024, 33(4): 107633.
|
| 51 |
Zeng W, Zhou F, Zhao H, et al. Evaluation of intensive statins and proprotein convertase subtilisin/kexin type 9 inhibitors on intracranial artery plaque stability: a prospective single-arm study [J]. J Am Heart Assoc, 2025, 14(2): e035651.
|
| 52 |
Alawneh JA, Moustafa RR, Baron JC. Hemodynamic factors and perfusion abnormalities in early neurological deterioration [J]. Stroke, 2009, 40(6): e443-e450.
|
| 53 |
Kim JT, Park MS, Chang J, et al. Proximal arterial occlusion in acute ischemic stroke with low NIHSS scores should not be considered as mild stroke [J]. PLoS One, 2013, 8(8): e70996.
|
| 54 |
Motta M, Ramadan A, Hillis AE, et al. Diffusion-perfusion mismatch: an opportunity for improvement in cortical function [J]. Front Neurol, 2014, 5: 280.
|
| 55 |
Hsu CY, Cheng CY, Tsal YH, et al. Perfusion-diffusion mismatch predicts early neurological deterioration in anterior circulation infarction without thrombolysis [J]. Curr Neurovasc Res, 2015, 12(3): 277-282.
|
| 56 |
中国卒中学会, 《中国卒中学会急性缺血性卒中再灌注治疗指南2024》编写组. 中国卒中学会急性缺血性卒中再灌注治疗指南2024 [J]. 中国卒中杂志, 2024, 19(12): 1460-1478.
|
| 57 |
Liu S, Cao W, Wu L, et al. Endovascular treatment over 24 hours after ischemic stroke onset: a single-center retrospective study [J]. Neuroradiology, 2023, 65(4): 793-804.
|